BioCentury | Oct 8, 2012
Company News
Sinclair IS Pharma, Valeant Pharmaceuticals sales and marketing update
...in Western Europe for €9 million ($11.6 million). The deal includes Sculptra , New-Fill and Succeev...
...to manage and prevent abnormal scars. Sculptra, a dermal filler that stimulates collagen growth, and Succeev...
...to manage and prevent abnormal scars. Sculptra, a dermal filler that stimulates collagen growth, and Succeev...
